FDA to Consider Genetically Modified Salmon for U.S. Consumption

September 23, 2010

The case for allowing genetically-modified food to enter the U.S. marketplace has taken a strong step forward. FDA recently (Rockville, MD) announced its intent to hold a meeting in mid-September with AquaBounty Technologies (Waltham, MA), a biotech company wishing to bring its genetically-modified salmon to market. The company says its AquAdvantage salmon grow twice as fast as conventionally grown salmon; but they do not grow bigger.

The case for allowing genetically-modified food to enter the U.S. marketplace has taken a strong step forward. FDA recently (Rockville, MD) announced its intent to hold a meeting in mid-September with AquaBounty Technologies (Waltham, MA), a biotech company wishing to bring its genetically-modified salmon to market.

The company says its AquAdvantage salmon grow twice as fast as conventionally grown salmon; but they do not grow bigger.

FDA has scheduled a two-day session for September 19-20, with the company and FDA...s Veterinary Medicine Advisory Committee, to overview data on safety and effectiveness of the salmon, and to allow for public opinion (only to individuals registered before the meeting).

According to the New York Times, FDA is expected to make a final decision on the approval of AquAdvantage salmon in the weeks following the meetings. If an approval is granted, it may take two to three years for the salmon to reach American markets, the New York Times added.

Nutritional Outlook will continue reporting on genetically modified organisms (GMOs) here at www.nutritionaloutlook.com.